ArticleInternational journal of clinical oncology2022

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study.

Shunsuke Kondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.